Bank of America Issues Pessimistic Forecast for Sutro Biopharma (NASDAQ:STRO) Stock Price
Sutro Biopharma (NASDAQ:STRO – Get Free Report) had its price objective dropped by analysts at Bank of America from $1.00 to $0.80 in a report issued on Monday,Benzinga reports. The brokerage presently has an “underperform” rating on the stock. Bank of America‘s price target indicates a potential downside of 11.08% from the company’s previous close. […]
Sutro Biopharma (NASDAQ:STRO – Get Free Report) had its price objective dropped by analysts at Bank of America from $1.00 to $0.80 in a report issued on Monday,Benzinga reports. The brokerage presently has an “underperform” rating on the stock. Bank of America‘s price target indicates a potential downside of 11.08% from the company’s previous close. […]
